-
1 Comment
Beijing Leadman Biochemistry Co.,Ltd is currently in a long term downtrend where the price is trading 6.5% below its 200 day moving average.
From a valuation standpoint, the stock is 48.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Beijing Leadman Biochemistry Co.,Ltd's total revenue rose by 34.8% to $149M since the same quarter in the previous year.
Its net income has increased by 322.0% to $11M since the same quarter in the previous year.
Finally, its free cash flow grew by 87.2% to $47M since the same quarter in the previous year.
Based on the above factors, Beijing Leadman Biochemistry Co.,Ltd gets an overall score of 4/5.
| ISIN | CNE100001C22 |
|---|---|
| Industry | Medical Devices |
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| Market Cap | 3B |
|---|---|
| Beta | 0.1 |
| PE Ratio | None |
| Dividend Yield | 0.4% |
| Target Price | 17 |
Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300289.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
